Victoria L Chiou

About Victoria L Chiou

Victoria L Chiou, MD, is Vice President, Clinical Development at Tempus AI. Dr Chiou is an oncology research physician with academic, industry, and regulatory experience in patient-centric drug development. Prior diverse clinical development experiences include Head, Clinical Excellence and Innovation, Late Development Oncology at AstraZeneca, where she led strategic development and implementation of global initiatives at the intersection of clinical cancer research, technology, and innovation; GlaxoSmithKline in cell therapy; and MedImmune/AstraZeneca in novel immuno-oncology drug combinations for treatment of multiple cancers. Dr Chiou also served as a medical officer at the US Food and Drug Administration, Office of Hematology and Oncology products.Dr Chiou completed her BA in human biology and psychology as a Jefferson Scholar at University of Virginia, MD at Medical College of Virginia, internal medicine residency at Wake Forest University, and medical oncology fellowship at National Institutes of Health, National Cancer Institute. Multiple career recognitions include Conquer Cancer Foundation of ASCO Merit Award, ASCO/AACR Methods in Clinical Cancer Research Workshop, SITC Women in Cancer Immunotherapy Network Leadership Institute, and Maryland Leading Women Under 40.

Experience

1. Vice President, Clinical Development

   Tempus AI

   Nov 2024 — Present

Education

• National Cancer Institute

  Medical Staff Fellow in Medical Oncology

  2015

• Medical College of Virginia

  Doctor of Medicine (MD)

  2010

• Wake Forest University

  Internal Medicine Residency Program

  2013

• University of Virginia

  BA, Human Biology, Psychology

  2006

Skills

• Cancer
• Oncology
• Cancer Research
• Clinical Trials
• Life Sciences
• Clinical Development
• Public Health
• Medicine
• Healthcare
• Clinical Research
• Breast Cancer
• Molecular Biology
• Translational Research
• Internal Medicine
• Medical Education
• Research